Back to All News

Phase 1 Clinical Trial of HOPO 14-1 Now Recruiting

Jun 9, 2023
The first-in-human Phase 1 clinical trial of the drug candidate HOPO 14-1 is now enrolling healthy participants. Questions about recruitment can be directed to clinical-trials@sri.com and full information, including eligibility requirements, can be found on ClinicalTrials.gov
ClinicalTrials.gov
Study of Single Oral Doses of HOPO 14-1 Evaluating Safety, Tolerability, Pharmacokinetics
More News & Publications
HOPO Therapeutics awarded BARDA contract of up to $226 million
Oct 3, 2024
HOPO Therapeutics awarded BARDA contract of up to $226 million
HOPO Therapeutics jointly awarded $1.78M ARPA-E Grant
Nov 2, 2023
HOPO Therapeutics jointly awarded $1.78M ARPA-E Grant
CEO Julian Rees named 2023 Activate Fellow
Jun 8, 2023
CEO Julian Rees named 2023 Activate Fellow
See all news
Stay up to date with research and development updates, news, and more on our mailing list.
HOPO Therapeutics
About UsScienceProgramsNews & PublicationsContact
5858 Horton St. Suite 393 
 Emeryville CA, 94608
info@hopotx.com
+1 (510) 239-3180
A Subsidiary of HOPO Technologies Group
© 2025 HOPO Therapeutics, Inc. All Rights Reserved.
TermsPrivacyDisclaimers